Cabenuva 600 mg/900 mg injection kit Images
Generic Name: cabotegravir/rilpivirine
This medication has been identified as Cabenuva 600 mg/900 mg injection kit. It is supplied by ViiV Healthcare.
Cabenuva is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. Cabenuva 600 mg/900 mg injection kit is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Cabenuva
- Generic Name
- cabotegravir/rilpivirine
- Strength
- 600 mg/900 mg injection kit
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare
- National Drug Code (NDC)
- 49702-0240
See also:
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
Abacavir
Abacavir is used for HIV Infection, nonoccupational exposure, occupational exposure
Lamivudine
Lamivudine is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational exposure
More about Cabenuva (cabotegravir / rilpivirine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (28)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.